Evidence map›Paper›PMID 34163352›Full record

ArticleFrontiers in pharmacology2021

Design of a Proteolytically Stable Sodium-Calcium Exchanger 1 Activator Peptide for

Pimthanya Wanichawan, Jonas Skogestad, Marianne Lunde, Thea Parsberg Støle, Maria Stensland, Tuula A Nyman, Ivar Sjaastad, Ole M Sejersted, Jan Magnus Aronsen, Cathrine Rein Carlson

Erratum issuedOpen access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Frontiers in pharmacology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact, top 96% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 0 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

10 authors at 3 institutions in 1 country.

Pimthanya WanichawanInstitute for Experimental Medical Research, Oslo University Hospital and University of Oslo, Oslo, Norway.
Jonas SkogestadInstitute for Experimental Medical Research, Oslo University Hospital and University of Oslo, Oslo, Norway.
Marianne LundeInstitute for Experimental Medical Research, Oslo University Hospital and University of Oslo, Oslo, Norway.
Thea Parsberg StøleInstitute for Experimental Medical Research, Oslo University Hospital and University of Oslo, Oslo, Norway.
Maria StenslandDepartment of Immunology, Institute of Clinical Medicine, University of Oslo and Rikshospitalet Oslo, Oslo, Norway.
Tuula A NymanDepartment of Immunology, Institute of Clinical Medicine, University of Oslo and Rikshospitalet Oslo, Oslo, Norway.
Ivar SjaastadInstitute for Experimental Medical Research, Oslo University Hospital and University of Oslo, Oslo, Norway.
Ole M SejerstedInstitute for Experimental Medical Research, Oslo University Hospital and University of Oslo, Oslo, Norway.
Jan Magnus AronsenDepartment of Molecular Medicine, Institute of Basic Medical Sciences, Faculty of Medicine, University of Oslo, Oslo, Norway.
Cathrine Rein CarlsonInstitute for Experimental Medical Research, Oslo University Hospital and University of Oslo, Oslo, Norway.
University of Oslo · NOInstitutt for Eksperimentell Medisinsk Forskning · NOOslo University Hospital · NO

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The cardiac sodium-calcium exchanger (NCX1) is important for normal Na

Indexed as

braincardiacdisruptor peptideNCX1NKApeptide arrayspeptidomimeticsPLM

Identifiers

PMID34163352
PMCPMC8215385
OpenAlexW3165973495

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.